Pathogenesis of Fulminant Type 1 Diabetes
- 1 January 2006
- journal article
- Published by JCFCorp SG PTE LTD in The Review of Diabetic Studies
- Vol. 3 (4), 169
- https://doi.org/10.1900/rds.2006.3.169
Abstract
Fulminant type 1 diabetes is a new subtype of type 1 diabetes. The term was established in 2000. It is a syndrome characterized by a markedly rapid and almost complete destruction of pancreatic beta-cells. Several lines of evidence suggest that both genetic factors, such as human leukocyte antigen (HLA), and environmental factors, such as viral infection, contribute to the development of this disease. It is also suggested that autoimmune processes contribute less critically to fulminant type 1 diabetes than to classic type 1A diabetes. Based on the findings made to date, both viral infection and the subsequent immune reaction in genetically susceptible individuals cause beta-cell destruction and lead to fulminant type 1 diabetes.Keywords
This publication has 40 references indexed in Scilit:
- T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetesDiabetologia, 2004
- Association of fulminant type 1 diabetes with pregnancyDiabetes Research and Clinical Practice, 2003
- HLA-DR-DQ Haplotype in Rapid-Onset Type 1 Diabetes in JapaneseDiabetes Care, 2003
- Association of HLA-DQ Genotype in Autoantibody-Negative and Rapid-Onset Type 1 DiabetesDiabetes Care, 2002
- A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related AntibodiesThe New England Journal of Medicine, 2000
- A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.Annals of Medicine, 2000
- Demonstration of Two Different Processes of β-Cell Regeneration in a New Diabetic Mouse Model Induced by Selective Perfusion of AlloxanDiabetes, 1997
- Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.JCI Insight, 1993
- Amelioration of Diabetes Mellitus in Partially Depancreatized Rats by Poly(ADP-ribose) Synthetase Inhibitors: Evidence of Islet B-Cell RegenerationDiabetes, 1984
- Thyrotrophin-binding inhibiting immunoglobulins (TBII) in subacute thyroiditis.1983